Perforating keratoplasty shows good morphological results with a clear cornea; however, a limiting factor is often the resulting astigmatism, which cannot be corrected with either glasses or contact lenses (CL) in up to 20% of the patients. We retrospectively investigated 15 patients after pseudophakic perforating keratoplasty, who received implantation of toric add-on intraocular lenses (IOL) to correct astigmatism. The mean preoperative astigmatism of 6.5 diopter (dpt) could be reduced to a mean postoperative value of 1.0 dpt. The mean visual acuity could be improved from a preoperative value of sc <0.05 (cc 0.6) to a postoperative value of sc 0.4 (cc 0.63). There were no complications except for one case of a lens extension tear. Based on our good experiences we now provide toric add-on IOL to all patients with pseudophakic perforating keratoplasty when this cannot be corrected or only insufficiently corrected by conservative methods.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1007/s00347-016-0386-6 | DOI Listing |
J Cataract Refract Surg
December 2024
From the Department of Ophthalmology, Saarland University Medical Center, Homburg/Saar, Germany (Berger, Abu Dail, Seitz, Khattabi, Flockerzi, Hamon, Daas); Department of Experimental Ophthalmology, Saarland University, Homburg/Saar, Germany (Langenbucher).
Purpose: To report functional and refractive outcomes of manual arcuate keratotomy (AK) with compression sutures for high regular postkeratoplasty astigmatism.
Setting: Department of Ophthalmology, Saarland University Medical Center, Homburg/Saar, Germany.
Design: Retrospective analysis.
Int Ophthalmol
July 2024
Rutgers New Jersey Medical School, Institute of Ophthalmology and Visual Science, 90 Bergen St, Newark, NJ, 07103, USA.
Purpose: This study evaluates the long-term adjunctive use of netarsudil ophthalmic solution 0.02% in lowering IOP in patients with refractory glaucoma.
Methods: This retrospective chart review study was conducted at a tertiary care center.
BMC Ophthalmol
July 2024
Department of Ophthalmology, The David J Apple Center for Vision Research, University of Heidelberg, Im Neuenheimer Feld 400, 69120, Heidelberg, Germany.
Front Physiol
May 2024
Department of Sports, Exercise and Health, Medical Faculty, University of Basel, Basel, Switzerland.
Background: Glaucoma stands as a prominent global cause of irreversible blindness and the primary treatment approach involves reducing intraocular pressure (IOP). However, around one-third of patients exhibit disease progression despite effective IOP reduction. Microvascular endothelial function, chronic inflammation, and oxidative stress are known to affect retinal neuronal networks and have been associated with disease severity and progression.
View Article and Find Full Text PDFAdv Ther
February 2024
Department of Ophthalmology, Tohoku University Graduate School of Medicine, 1-1 Seiryo-machi, Aoba-ku, Sendai, Miyagi, 980-8574, Japan.
Introduction: Our study was conducted to determine factors associated with the effectiveness of a β-blocker eye drop add-on in altering pulse rate (PR) in glaucoma patients.
Methods: This retrospective study examined 236 eyes of 138 patients who received a β-blocker eye drop add-on during follow-up. Patients were included if at least one PR measurement was available both before and after the add-on was started.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!